Search

everythinglearnresearchcommunity

for

Search:↓

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Tiny particles from stem cells help activate hair growth cells and encourage hair growth in mice without being toxic.

Hyperandrogenism and insulin resistance in PCOS-like rats can lead to pregnancy complications due to increased cell death in the uterus and placenta.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

HPT axis hormones boost mitochondrial function and growth in hair follicles, potentially aiding hair health.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Future acne treatments should aggressively target inflammation to prevent scarring.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Electrospun nanofibers show promise for enhancing blood vessel growth in tissue engineering but need further research to improve their effectiveness.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

The new matrix improves skin regeneration and graft performance.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Spermidine may help reduce hair loss and deserves further testing as a treatment.